Title |
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
|
---|---|
Published by |
John Wiley & Sons, Ltd, September 2013
|
DOI | 10.1002/14651858.cd009552.pub2 |
Pubmed ID | |
Authors |
Cheyne, Leanne, Irvin-Sellers, Melanie J, White, John |
Abstract |
Tiotropium and ipratropium bromide are both recognised treatments in the management of people with stable chronic obstructive pulmonary disease (COPD). There are new studies which have compared tiotropium with ipratropium bromide, making an update necessary. |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 17% |
Spain | 3 | 13% |
United Kingdom | 2 | 9% |
Canada | 1 | 4% |
Switzerland | 1 | 4% |
Unknown | 12 | 52% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 18 | 78% |
Practitioners (doctors, other healthcare professionals) | 2 | 9% |
Science communicators (journalists, bloggers, editors) | 2 | 9% |
Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Sweden | 1 | 2% |
Unknown | 63 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 28% |
Student > Bachelor | 7 | 11% |
Other | 6 | 9% |
Researcher | 6 | 9% |
Student > Ph. D. Student | 6 | 9% |
Other | 13 | 20% |
Unknown | 8 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 48% |
Nursing and Health Professions | 9 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 11% |
Social Sciences | 3 | 5% |
Chemistry | 2 | 3% |
Other | 4 | 6% |
Unknown | 8 | 13% |